|
⚲
|
| Keyboard |
| Patni Rajiv
✚
|
|
|---|---|
| CIK # | 0001616200 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001616200] | |
| 4 | [0001616200] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Patni Rajiv | |
| BioXcel Therapeutics Inc | |
| Quince Therapeutics Inc | |
| Reata Pharmaceuticals Inc | |
| Portola Pharmaceuticals Inc | |
| Adamas Pharmaceuticals Inc | |
| Tranzyme Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
BioXcel Therapeutics Inc BTAI
Stock Option (Right to Buy) · derivative
|
2026-01-09 | Grant | 17,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Director Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 27,000 | $0.00 | |
|
BioXcel Therapeutics Inc BTAI
Stock Option (right to buy) · derivative
|
2025-01-15 | Grant | 44,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (right to buy) · derivative
|
2024-06-05 | Grant | 13,500 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (right to buy) · derivative
|
2024-02-15 | Grant | 54,000 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-09-26 | Disposed to issuer | 45,000 | ||
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2023-09-26 | Disposed to issuer | 90,000 | ||
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right-to-buy) · derivative
|
2023-06-12 | Grant | 90,000 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-06-12 | Grant | 45,000 | $0.00 | |
|
Portola Pharmaceuticals Inc PTLA
Restricted Stock Units · derivative
|
2020-07-02 | Disposed to issuer | 35,000 | $0.00 | |
|
Portola Pharmaceuticals Inc PTLA
Stock Option (Right to Buy) · derivative
|
2020-07-02 | Disposed to issuer | 125,000 | $7.89 | 986,250 |
|
Portola Pharmaceuticals Inc PTLA
Common Stock
|
2020-02-28 | Grant | 35,000 | $0.00 | |
|
Portola Pharmaceuticals Inc PTLA
Stock Option (Right to Buy) · derivative
|
2020-02-28 | Grant | 125,000 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2019-04-08 | Grant | 30,000 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2019-04-08 | Grant | 60,000 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2019-03-20 | Sell | 2,374 | $8.00 | 18,992 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2018-03-21 | Sell | 1,252 | $25.94 | 32,477 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2018-03-06 | Grant | 9,125 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2018-03-06 | Grant | 54,750 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2017-03-21 | Sell | 733 | $17.04 | 12,490 |
| showing 20 of 29 most recent transactions | |||||